Rating History for Halozyme Therapeutics (HALO) by Leerink
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/7/2026 | David Risinger | Upgrade | Outperform (Market Perform) |
110.00 (83.00) |
85.76 (107.72) |
25.61% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
